Myriad Genetics has launched its myRisk next-generation sequencing-based hereditary cancer panel to early access users (see story, this issue). The test analyzes 25 genes associated with eight different inherited cancers, including: breast, colorectal, ovarian, endometrial, pancreatic, prostate, gastric, and melanoma.
New Products: Myriad's myRisk Panel
Premium